Conceptualizing a Model
暂无分享,去创建一个
Murray Krahn | A David Paltiel | Michael Chambers | Louise B Russell | Phil McEwan | Mark Roberts | L. Russell | M. Krahn | A. Paltiel | Michael Chambers | P. McEwan | Mark Roberts | A. Paltiel | P. Mcewan | A. D. Paltiel
[1] R. Shavelson,et al. Problems and Issues in the Use of Concept Maps in Science Assessment. , 1996 .
[2] Harlan M. Krumholz,et al. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. , 1992, The New England journal of medicine.
[3] P. A. Mileman. Decision making in health care. Theory, psychology, and applications , 2001 .
[4] Oguzhan Alagoz,et al. A Clinically Based Discrete-Event Simulation of End-Stage Liver Disease and the Organ Allocation Process , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.
[5] Stirling Bryan,et al. Modelling in the economic evaluation of health care: selecting the appropriate approach , 2004, Journal of health services research & policy.
[6] J. Best,et al. STRATEGY FOR RUBELLA VACCINATION , 1983, The Lancet.
[7] Oguzhan Alagoz,et al. Estimating the Unknown Parameters of the Natural History of Metachronous Colorectal Cancer Using Discrete-Event Simulation , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[8] David M Eddy,et al. Validation of the archimedes diabetes model. , 2003, Diabetes care.
[9] R. Willke,et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[10] Eric J Feuer,et al. Dynamic Microsimulation Models for Health Outcomes , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[11] Medical Advisory Secretariat. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis. , 2010, Ontario health technology assessment series.
[12] A. Mulley,et al. Management of acute dysuria. A decision-analysis model of alternative strategies. , 1985, Annals of internal medicine.
[13] James E. Stahl,et al. Pharmacoeconomics 2008; 26 (2): 131-148 , 2012 .
[14] Jonathan Karnon,et al. Model Parameter Estimation and Uncertainty: a Report of the Ispor-smdm Modeling Good Research Practices Task Force-6 Background to the Task Forcemodel-parameter-estimation-and- Uncertainty-analysis.asp). a Summary of These Articles Was Pre- Sented at a Plenary Session at the Ispor 16th Annual Intern , 2022 .
[15] J. Caro,et al. Modeling Using Discrete Event Simulation , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.
[16] M L Brandeau,et al. HIV transmission and the cost-effectiveness of methadone maintenance. , 2000, American journal of public health.
[17] Giovanni Parmigiani,et al. The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions , 1997, Annals of Internal Medicine.
[18] Peter J Neumann,et al. Costing and Perspective in Published Cost-Effectiveness Analysis , 2009, Medical care.
[19] M. Drummond,et al. Conflict of interest in industrysponsored economic evaluations: Real or imagined? , 2001, Current oncology reports.
[20] Alberto J. Cañas,et al. Florida Institute for Human and Machine Cognition (IHMC) , 2011 .
[21] W. Leslie,et al. The dynamics of HIV spread: a computer simulation model. , 1990, Computers and biomedical research, an international journal.
[22] M. Weinstein,et al. QALYs: the basics. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[23] Anke Richter,et al. Health and Economic Impacts of an HIV Intervention in Out of Treatment Substance Abusers: Evidence from a Dynamic Model , 2005, Health care management science.
[24] David Henry,et al. Economic Analysis as an Aid to Subsidisation Decisions , 2012, PharmacoEconomics.
[25] A S Detsky,et al. Primer on Medical Decision Analysis: Part 1—Getting Started , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.
[26] Dan Greenberg,et al. Bias in published cost effectiveness studies: systematic review , 2006, BMJ : British Medical Journal.
[27] Marvin Zelen,et al. Clinical Guidelines Annals of Internal Medicine Effects of Mammography Screening Under Different Screening , 2022 .
[28] Uwe Siebert,et al. Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[29] David M. Eddy,et al. Archimedes: a new model for simulating health care systems--the mathematical formulation , 2002, J. Biomed. Informatics.
[30] M Sculpher,et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. , 2004, Health technology assessment.
[31] D. Owens,et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[32] S. Blower,et al. Amplification Dynamics: Predicting the Effect of HIV on Tuberculosis Outbreaks , 2001, Journal of acquired immune deficiency syndromes.
[33] J. Caro,et al. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[34] Chien-Chang Lee,et al. Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. , 2007 .
[35] D K Owens,et al. Use of Influence Diagrams to Structure Medical Decisions , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.
[36] Mirjam Kretzschmar,et al. Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5 , 2012, Value in Health.
[37] Gilles Clermont,et al. Equation-based models of dynamic biological systems. , 2008, Journal of critical care.
[38] M C Weinstein,et al. The cost-effectiveness of preventing AIDS-related opportunistic infections. , 1998, JAMA.
[39] S. Golder,et al. Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment , 2012, PharmacoEconomics.
[40] Gilles Clermont,et al. A MATHEMATICAL SIMULATION OF THE INFLAMMATORY RESPONSE TO ANTHRAX INFECTION , 2008, Shock.
[41] Sue J Goldie,et al. Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches. , 2008, PharmacoEconomics.
[42] Douglas K Owens,et al. Potential population health outcomes and expenditures of HIV vaccination strategies in the United States. , 2009, Vaccine.
[43] Przemyslaw Perlikowski,et al. Understanding Coin-Tossing , 2010 .
[44] Martin O'Flaherty,et al. Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[45] Jonathan Karnon,et al. Model Parameter Estimation and Uncertainty Analysis , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.
[46] Benjamin P. Linas,et al. Improving Outcomes in State AIDS Drug Assistance Programs , 2009, Journal of acquired immune deficiency syndromes.
[47] J. Eisenberg,et al. Clinical Economics: A Guide to the Economic Analysis of Clinical Practices , 1989 .
[48] R. Rosenheck,et al. Quantitative analysis of sponsorship bias in economic studies of antidepressants. , 2003, The British journal of psychiatry : the journal of mental science.
[49] Daniel Kahneman,et al. A different approach to health state valuation. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[50] A. Miners,et al. Exploration of the difference in results of economic submissions to the National Institute of Clinical Excellence by manufacturers and assessment groups , 2007, International Journal of Technology Assessment in Health Care.
[51] Michael Drummond,et al. Moving the QALY forward: rationale for change. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[52] Mirjam Kretzschmar,et al. Dynamic Transmission Modeling , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.
[53] Ross D. Shachter,et al. Representation and Analysis of Medical Decision Problems with Influence Diagrams , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.
[54] L. Goldman,et al. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. , 1987, American journal of public health.
[55] Amy H Auchincloss,et al. A new tool for epidemiology: the usefulness of dynamic-agent models in understanding place effects on health. , 2008, American journal of epidemiology.
[56] G. Clermont,et al. In silico design of clinical trials: A method coming of age , 2004, Critical care medicine.
[57] Erik Buskens,et al. A tutorial on discrete-event simulation for health policy design and decision making: optimizing pediatric ultrasound screening for hip dysplasia as an illustration. , 2009, Health policy.
[58] Chris T Bauch,et al. Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience. , 2010, Vaccine.
[59] A S Detsky,et al. Primer on Medical Decision Analysis: Part 2—Building a Tree , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.